Xiaozhong Chen, MD

Capecitabine

1 trial

phase_2

Anlotinib hydrochloride

A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors

+7 more interventions

15 unique interventions2 categories

Analytics

Trial Phases

Phase 11

Phase 25

Phase 32

Trial Status

Completed2

Other5

Role Distribution

Principal Investigator6

Other Roles1

PI Rate86%

Activity Timeline

Clinical Trials (7)

NCT05229497Phase 1/2Active Not Recruiting

Advanced Malignant Tumors

PrincipalinvestigatorStart date: 2022-05-04

NCT04974398Phase 3Active Not Recruiting

A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

PrincipalinvestigatorStart date: 2021-08-16

NCT04736810Phase 2Completed

A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

StudychairStart date: 2021-02-25

NCT03025958Phase 2Completed

Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

PrincipalinvestigatorStart date: 2017-03-13

NCT01536223Phase 3Unknown

Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma

ChemoradiationNasopharyngeal Carcinoma

Principalinvestigator

NCT03678649Phase 2Unknown

A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC

Head and Neck Neoplasms

Principalinvestigator

NCT07794488Phase 2Not Yet Recruiting

Platinum-Free Regimen in Nasopharyngeal Carcinoma

Nasopharyngeal Cancinoma (NPC)

Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Nasopharyngeal Carcinoma4 Advanced Malignant Tumors1 Chemoradiation1 Head and Neck Neoplasms1 Nasopharyngeal Cancinoma (NPC)1

Affiliations

Zhejiang Cancer Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Chaosu Hu, MD

Fudan University

2 trials

Shared therapeutic areas:

Nasopharyngeal Carcinoma

Worked with same sponsors:

AkesoAkeso Tiancheng, Inc

Collaborated on 1 trial

Similarity Score14%

Lizhi Niu, PhD

Fuda Cancer Hospital

31 trials

Shared therapeutic areas:

Head and Neck NeoplasmsNasopharyngeal Carcinoma

Head and Neck NeoplasmsNasopharyngeal Carcinoma

Jennifer Johnson, MD, PhD

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

5 trials

Shared therapeutic areas:

Head and Neck NeoplasmsNasopharyngeal Carcinoma

Vivek Subbiah, MD

M.D. Anderson Cancer Center

7 trials

Shared therapeutic areas:

Nasopharyngeal CarcinomaNasopharyngeal Cancinoma (NPC)

Jun Ma, M.D.

Sun Yat-sen University

10 trials

Shared therapeutic areas:

Nasopharyngeal CarcinomaHead and Neck Neoplasms

Ming-Yuan Chen, MD,PhD

Sun Yat-sen University

8 trials

Shared therapeutic areas:

Shivaani Kummar, M.D.

National Cancer Institute (NCI)

9 trials

Shared therapeutic areas:

Head and Neck Neoplasms

Georges Paizis, MD

Sanofi

7 trials

Shared therapeutic areas:

Head and Neck Neoplasms

Nasopharyngeal Cancinoma (NPC)

Allan Hildesheim, Ph.D.

National Cancer Institute (NCI)

6 trials

Shared therapeutic areas:

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

14 trials

Shared therapeutic areas:

Nasopharyngeal Carcinoma